Hong Kong SAR

Chinese state-owned investment bank Shenwan Hongyuan Group kicked off pre-marketing on Monday for its Hong Kong IPO.

Chinese technology company Duiba Group reaffirmed its IPO hopes on Monday, once again filing a prospectus with the Hong Kong stock exchange.

China Everbright Greentech, an environmental protection service provider under China Everbright International, has closed a green loan of HK$1bn ($127m).

Sportswear firm Xtep International Holdings has raised HK$1.37bn ($175m) after increasing the size of a top-up placement on the back of strong new and existing shareholder demand.

Sino Biopharmaceutical has increased its refinancing loan to $1bn after receiving a strong response during syndication.

Hong Kong’s stock exchange took a progressive step in 2018 when it allowed pre-revenue biotechnology companies to list. But the initial excitement was short lived, with the stocks’ dismal performance in the aftermarket denting sentiment among issuers, bankers and investors. Will the tide turn for the sector this year? Jonathan Breen investigates.

Hong Kong’s Konew International Group has debuted in the offshore loans market, raising $150m.

Real estate developer China Vanke Co has raised HK$7.81bn ($994.3m) from a placement of new shares, its second tap of the Hong Kong market.

Chinese pharmaceuticals company WuXi Biologics has launched a debut offshore loan of $200m through sole lead Standard Chartered.

South African mining company Heaven-Sent Gold Group is planning a Hong Kong IPO, having filed a draft prospectus through sole sponsor CLSA on Tuesday.

JP Morgan has appointed Paul Uren to replace the outgoing co-head of global investment banking coverage for Asia Pacific, according to an internal memo seen by GlobalCapital Asia.

China Railway Signal and Communication Corporation (CRSC), a Hong Kong-listed red-chip company, is seeking a Rmb10.5bn ($1.56bn) IPO on the new Shanghai Science and Technology Innovation board.